κ-Opioid receptor stimulation contributes to aortic artery dilation through activation of K ATP channel in the rats

Acta Physiologica Sinica

Volumn 55, Issue 1, 2003, Pages 91-95

  Pei, Jian Ming ^a   Chen, Mai ^b   Wang, Yao Min ^a   Wen, Jun ^a   Zhu, Yun Long ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

opioid receptor; Aortic ring perfusion; Hysiology; K ATP channel; Rat

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ADENOSINE TRIPHOSPHATE; ATROPINE; BETA ADRENERGIC RECEPTOR; GLIBENCLAMIDE; GLIPIZIDE; INDOMETACIN; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MUSCARINIC RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROPRANOLOL; PROSTAGLANDIN;

ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; MALE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; RAT; VASCULAR RING;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; AORTA; KATP CHANNELS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; VASODILATION;

EID: 0037465191     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Krumins SA, Faden AI, Feuerstein G. Opiate binding in rat hearts: modulation of binding after hemorrhagic shock. Biochem Biophys Res Commun 1985;127:120-128.
2. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C. Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 1989;987:69-74.
3. 3H] U69593 binding sites in the rat heart by receptor binding assays. J Mol Cell Cardiol 1991;23:1297-1302.
4. Zhang, WM, Jin WQ, Wong TM. Multiplicity of kappa opioid receptor binding in the rat cardiac sarcolemma. J Mol Cell Cardiol 1996;28:1547-1554.
5. 3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart. Br J Pharmacol 1997;120:827-832.
6. Sun FY, Yu GH, Zhang AZ. κ-opioid receptor in the vessel. Acta Pharmacol Sin 1983;4:100.
7. Weihe E, Mcknight AT, Corbert AD, Kosterlitz HW. Proenkephalin- and prodynorphin-derived peptides in guinea-heart. Neuropeptide 1985;5:453-456.
8. Canossa M, Ventura C, Vaona I, Carboni I, Guanieri C, Spampinato S. Prodynorphin mRNA expression in adult cultured rat ventricular cardiac myocytes. Biochem Biophys Acta 1993;1172:247-250.
9. Ventura C, Guarnieri C, Vaona I, Campana G, Pintus G, Spampinato S. Dynorphin gene expression and release in the myocardial cell. J Biol Chem 1994;269:5384-5386.
10. Sun FY, Zhang AZ. Dynorphin receptor in the blood vessel. Neuropeptides 1985;5:595-598.
11. McLaughlin PJ. Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5] enkephalin. Am J Physiol 1996;271:R122-R129.
12. Xia Q, Sheng JZ, Tai KK, Wong TM. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat hearts. J Pharmacol Exp Ther 1994;268:930-934.
13. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte involvement of κ-opioid receptor. Circ Res 1999;84:1388-1395.
14. Yu XC, Wang HX, Zhang WM, Wong TM. Cross-talk between cardiac κ-opioid and β-adrenergic receptors in developing hypertensive rats. J Mol Cell Cardiol 1999;31:597-605.
15. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, Ferri C, Desideri G, Chiariello L, Gioffre PA. Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 1999;33:1863-1869.
16. Yu XC, Wang HX, Pei JM, Wong TM. Anti-arrhythmic effect of κ-opioid receptor stimulation in the perfused rat heart: Involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 1999;31:1809-1819.
17. Bian JS, Zhang WM, Xia Q, Wong TM. Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart. J Mol Cell Cardiol 1998;30:2103-2110.
18. Yu XC, Li HY, Wang HX, Wong TM. U50488H inhibits effects of norepinephrine in rat cardiomyocytes - cross-talk between κ-opioid and β-adrenoceptors. J Mol Cell Cardiol 1998;30:405-413.
19. + channels. Am J Physiol 1995;269:H997-H1002.
20. El-Sharkawy TY, al-Shireida MF, Pilcher CW. Vascular effects of some opioid receptor agonists. Can J Physiol Pharmacol 1991;69:846-851.
21. Wang YX, Legzdins P, Poon JS, Pang CCY. Vasodilator effects of organotransition-metal nitrosyl complexes, novel nitric oxide donors. J Cardiovasc Pharmacol 2000;35:73-77.
22. Takemori AE, Ho BY, Naeseth JS, Portoghese PS. Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther 1988;246:255-258.
23. Devine JO, William M. The role of nitric oxide in opioid-induced pial artery vasodilation. Brain Res 1995;675:257-263.
24. Brayden JE. Membrane hyperpolarization is a mechanism of vendothelium-dependent cerebral vasodilation. Am J Physiol 1990;259:H668-H673.
25. Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78:1100-1104.